FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079132508> ?p ?o ?g. }

• W2079132508 endingPage "586" @default.
• W2079132508 startingPage "579" @default.
• W2079132508 abstract "As reported previously, cyclophosphamide plus tumor necrosis factor-alpha treatment of C57BL/6 mice bearing advanced EL4 lymphoma induced approx. 60% long-term (i.e., >60 days) survivors. These mice developed protective immunity, as evidenced by 1) rejection (100% survival) of EL4 tumor re-implanted on day 60 (day 0 = initial tumor implantation); and 2) development of significant levels of specific EL4 tumor cell killing activity by both splenocytes and thymocytes. Using this model, age-related changes in functionally and phenotypically definable thymocyte subsets were assessed. In thymocytes from 90 to 308 day survivors, specific immune memory was long term; both CD4+ and CD8+ cells were required for the ex vivo stimulation of lytic activity, but the specific anti-EL4 cytotoxic effector was CD4-CD8+. On day 520, the surviving mice were randomized into 2 groups. One group received a second re-challenge with EL4 tumor cells and all survived. The other group was sacrificed on day 520. Their thymocytes, exposed to X-irradiated EL4, developed anti-EL4 lytic activity and, in comparison with thymocytes of young and age-matched control mice, were markedly enriched in CD4-CD8+CD44+ cells. On day 625, thymocytes from the survivors of the day 520 re-challenge were evaluated and were found to have developed specific anti-EL4 lytic activity. Phenotypically, they had returned toward the pattern seen in age-matched control mice although CD4-CD8+CD44+ cells remained increased. These mice were > or = 2 years old, the median life span of C57BL/6 mice. Thus, mice cured of tumor by an immuno-modulating regimen rejected re-implanted primary tumor and maintained specific thymic anti-tumor immune memory for life." @default.
• W2079132508 created "2016-06-24" @default.
• W2079132508 creator A5003400884 @default.
• W2079132508 creator A5063228708 @default.
• W2079132508 creator A5064359364 @default.
• W2079132508 creator A5067906247 @default.
• W2079132508 creator A5069987545 @default.
• W2079132508 creator A5076263166 @default.
• W2079132508 creator A5079009180 @default.
• W2079132508 creator A5085521139 @default.
• W2079132508 creator A5021970878 @default.
• W2079132508 date "1998-05-18" @default.
• W2079132508 modified "2023-09-25" @default.
• W2079132508 title "Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation" @default.
• W2079132508 cites W1596226163 @default.
• W2079132508 cites W1890068101 @default.
• W2079132508 cites W1967412875 @default.
• W2079132508 cites W1968453816 @default.
• W2079132508 cites W1973591436 @default.
• W2079132508 cites W1977656461 @default.
• W2079132508 cites W1998783073 @default.
• W2079132508 cites W1999296675 @default.
• W2079132508 cites W2018416540 @default.
• W2079132508 cites W2023809975 @default.
• W2079132508 cites W2024276789 @default.
• W2079132508 cites W2029869543 @default.
• W2079132508 cites W2033167678 @default.
• W2079132508 cites W2064139333 @default.
• W2079132508 cites W2084217233 @default.
• W2079132508 cites W2087792479 @default.
• W2079132508 cites W2104081425 @default.
• W2079132508 cites W2158500407 @default.
• W2079132508 cites W2162543584 @default.
• W2079132508 doi "https://doi.org/10.1002/(sici)1097-0215(19980518)76:4<579::aid-ijc22>3.0.co;2-1" @default.
• W2079132508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9590137" @default.
• W2079132508 hasPublicationYear "1998" @default.
• W2079132508 type Work @default.
• W2079132508 sameAs 2079132508 @default.
• W2079132508 citedByCount "9" @default.
• W2079132508 countsByYear W20791325082013 @default.
• W2079132508 crossrefType "journal-article" @default.
• W2079132508 hasAuthorship W2079132508A5003400884 @default.
• W2079132508 hasAuthorship W2079132508A5021970878 @default.
• W2079132508 hasAuthorship W2079132508A5063228708 @default.
• W2079132508 hasAuthorship W2079132508A5064359364 @default.
• W2079132508 hasAuthorship W2079132508A5067906247 @default.
• W2079132508 hasAuthorship W2079132508A5069987545 @default.
• W2079132508 hasAuthorship W2079132508A5076263166 @default.
• W2079132508 hasAuthorship W2079132508A5079009180 @default.
• W2079132508 hasAuthorship W2079132508A5085521139 @default.
• W2079132508 hasBestOaLocation W20791325081 @default.
• W2079132508 hasConcept C126322002 @default.
• W2079132508 hasConcept C154317977 @default.
• W2079132508 hasConcept C16685009 @default.
• W2079132508 hasConcept C167672396 @default.
• W2079132508 hasConcept C17991360 @default.
• W2079132508 hasConcept C202751555 @default.
• W2079132508 hasConcept C203014093 @default.
• W2079132508 hasConcept C2776694085 @default.
• W2079132508 hasConcept C2776755627 @default.
• W2079132508 hasConcept C2778954852 @default.
• W2079132508 hasConcept C2779338263 @default.
• W2079132508 hasConcept C55493867 @default.
• W2079132508 hasConcept C71924100 @default.
• W2079132508 hasConcept C86803240 @default.
• W2079132508 hasConcept C8891405 @default.
• W2079132508 hasConceptScore W2079132508C126322002 @default.
• W2079132508 hasConceptScore W2079132508C154317977 @default.
• W2079132508 hasConceptScore W2079132508C16685009 @default.
• W2079132508 hasConceptScore W2079132508C167672396 @default.
• W2079132508 hasConceptScore W2079132508C17991360 @default.
• W2079132508 hasConceptScore W2079132508C202751555 @default.
• W2079132508 hasConceptScore W2079132508C203014093 @default.
• W2079132508 hasConceptScore W2079132508C2776694085 @default.
• W2079132508 hasConceptScore W2079132508C2776755627 @default.
• W2079132508 hasConceptScore W2079132508C2778954852 @default.
• W2079132508 hasConceptScore W2079132508C2779338263 @default.
• W2079132508 hasConceptScore W2079132508C55493867 @default.
• W2079132508 hasConceptScore W2079132508C71924100 @default.
• W2079132508 hasConceptScore W2079132508C86803240 @default.
• W2079132508 hasConceptScore W2079132508C8891405 @default.
• W2079132508 hasIssue "4" @default.
• W2079132508 hasLocation W20791325081 @default.
• W2079132508 hasLocation W20791325082 @default.
• W2079132508 hasOpenAccess W2079132508 @default.
• W2079132508 hasPrimaryLocation W20791325081 @default.
• W2079132508 hasRelatedWork W1545727386 @default.
• W2079132508 hasRelatedWork W2018916009 @default.
• W2079132508 hasRelatedWork W2054101033 @default.
• W2079132508 hasRelatedWork W2078447006 @default.
• W2079132508 hasRelatedWork W2136885844 @default.
• W2079132508 hasRelatedWork W2327592239 @default.
• W2079132508 hasRelatedWork W2821255169 @default.
• W2079132508 hasRelatedWork W2981642747 @default.
• W2079132508 hasRelatedWork W4320081937 @default.
• W2079132508 hasRelatedWork W4320717881 @default.
• W2079132508 hasVolume "76" @default.
• W2079132508 isParatext "false" @default.

• next